Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1999
12/21/1999US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999CA2150552C Antithrombotic
12/21/1999CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/21/1999CA2044280C Vitamin d analogues
12/16/1999WO1999064585A2 Novel angiotensin receptor, production and use thereof
12/16/1999WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999WO1999064411A1 Tetrahydroquinoline derivatives as glycine antagonists
12/16/1999WO1999064410A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
12/16/1999WO1999064409A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064062A1 New therapeutic use of pkb (proteine kinase b) enhancers
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064028A1 Protecting neurons from ischemia
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063981A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
12/16/1999WO1999049877A3 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
12/16/1999WO1999049015A3 Cardiac-derived stem cells
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999DE19825804A1 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung 1,4-benzothiazepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
12/16/1999CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2332314A1 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999CA2331918A1 Protecting neurons from ischemia
12/16/1999CA2330229A1 Novel angiotensin receptor, production and use thereof
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318901A1 Novel calcium channel drugs and uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999EP0963983A1 Indol-2-ones as serotonin modulators
12/15/1999EP0963756A2 Inhibition of LDL oxidation and atherosclerosis
12/15/1999EP0963431A1 NOVEL FabH
12/15/1999EP0963370A1 Integrin antagonists
12/15/1999EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/15/1999EP0643585B1 The use of Lipoprotein Associated Coagulation Inhibitor (LACI) for the preparation of a medicament for the treatment of acute or chronic inflammation.
12/15/1999EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999EP0610439B1 Pyrimidocycloalkanes as angiotensin ii antagonists
12/15/1999CN1238773A Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
12/15/1999CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999CN1238766A 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
12/15/1999CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999CN1238702A Radiolabeled DNA oligonuleotide, method of preparation and therapeutic uses
12/15/1999CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound
12/15/1999CN1238689A Vitronectin receptor antagonists
1 ... 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 ... 1595